Hirasawa, Yosuke
Adachi, Takahiro
Hashimoto, Takeshi
Fukuokaya, Wataru
Koike, Yuhei
Yata, Yuji
Komura, Kazumasa
Uchimoto, Taizo
Tsujino, Takuya
Nishimura, Kazuki
Takahara, Kiyoshi
Saruta, Masanobu
Fujita, Kazutoshi
Hashimoto, Mamoru
Uemura, Hirotsugu
Shiroki, Ryoichi
Azuma, Takashi
Kimura, Takahiro
Ohno, Yoshio
Funding for this research was provided by:
Japan Society for the Promotion of Science: JSPS (22K09512)
Article History
Received: 13 February 2024
Accepted: 21 March 2024
First Online: 9 April 2024
Declarations
:
: All authors have no conflicts of interest to disclose.
: This study was approved by the Institutional Review Board (IRB) from Osaka Medical and Pharmaceutical University (approval number: RIN-750–2571, approved on 24th January 2020). This observational study adhered to ethical principles aligned with the Declaration of Helsinki, the International Conference on Harmonisation's Good Clinical Practice guidelines, Good Pharmacoepidemiology Practices, and relevant laws for noninterventional and observational studies.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.